Share Name Share Symbol Market Type Share ISIN Share Description
Animalcare Group Plc LSE:ANCR London Ordinary Share GB0032350695 ORD 20P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.00 -0.87% 342.00 334.00 350.00 345.00 342.00 345.00 4,566 09:00:22
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food Producers 70.5 0.2 0.4 855.0 206

Animalcare Group PLC Half Year Trading Update and Notice of Results

22/07/2021 7:00am

UK Regulatory (RNS & others)

Animalcare (LSE:ANCR)
Historical Stock Chart

From May 2021 to Nov 2021

Click Here for more Animalcare Charts.


RNS Number : 0545G

Animalcare Group PLC

22 July 2021


("Animalcare" or the "Group" or the "Company")

Half Year Trading Update and Notice of Results

22 July 2021. Animalcare Group plc (AIM: ANCR), the international animal health business, provides the following unaudited trading update for the six months ended 30 June 2021 ahead of publishing its interim results on 28 September 2021.

Trading overview

Animalcare is pleased to report a double-digit increase in revenues and further strengthening of its financial position in the first half. Thanks to the outstanding commitment of our team the Group continues to perform strongly and implement its long-term growth strategy.

Total sales for the period were GBP39.1m, an increase of GBP4.6m or 13% (14% at CER) on the prior year helped by increased veterinary demand. We saw growth across our markets with the Companion Animals portfolio the driving factor. The Group's position in this growing segment of the market is due to receive a further boost as ongoing investment in the pipeline and business development delivers. Notably, Daxocox launch activities commenced at the end of the first half while the STEM dental range of products remains on track to complete manufacturing transfer and launch in late Q4.

The rate of growth in underlying EBITDA for the first six months is expected to be ahead of revenue, reflecting a higher margin product mix and positive leverage over the period. Recognising the beneficial effect of phasing during the first half, and consistent with Board expectations, we maintain our outlook of increased revenues for the full year.

Continuing strong cash generation drove further reduction in net debt in the period. Accounting for payment of the final dividend post-year end, net debt is approximately GBP10.1m, down by around GBP3.5m (26%) from 31 December 2020 (GBP13.6m). As a result, the net debt to underlying EBITDA leverage ratio is well below our target range of 1.0 to 2.0 times, further strengthening our financial position to enable investment in future growth which remains a key strategic objective.

Commenting on first half trading, Jenny Winter, Chief Executive Officer said: "We're delighted to have made such a positive start to the year after a challenging 2020 for the Animalcare team and our customers. Focused execution of our growth strategy has enabled us to take advantage of increased demand across our markets and further strengthen our financial platform as we pursue opportunities that will create long-term value. Our outlook for the full year remains unchanged at this time and we remain upbeat on the prospects for the Group.

"We are now in full launch mode for Daxocox and though it's still early in the journey for this differentiated new pain treatment we are excited about the response we are getting from our customers."

Board update

As announced on 8 July 2021, following the sale of Ecuphar Invest NV's shareholding in the Group through a secondary placing, Christiaan Cardon has resigned from the Animalcare Board and a non-executive recruitment process has been initiated. The Board would like to take this opportunity to welcome new shareholders to the Group and thank existing investors for their ongoing support. The Board also wishes to record its appreciation for Christiaan's service and contribution to the business since joining the Group in 2017, originally as an Executive and subsequently a Non-Executive Director.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.


 Animalcare Group plc                +44 (0)1904 487 687 
  Jenny Winter, Chief Executive 
  Chris Brewster, Chief Financial     communications@animalcaregroup.com 
  Media relations 
 Stifel Nicolaus Europe Limited 
  (Nominated Adviser & Joint 
  Ben Maddison 
  Fred Walsh 
  Nick Adams                         +44 (0)20 7710 7600 
 Panmure Gordon 
  (Joint Broker) 
  Corporate Finance 
  Freddy Crossley/Emma Earl 
  Corporate Broking 
  Rupert Dearden                     +44 (0)20 7886 2500 

About Animalcare www.animalcaregroup.com

Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organisation. Animalcare operates in seven countries and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

July 22, 2021 02:00 ET (06:00 GMT)

1 Year Animalcare Chart

1 Year Animalcare Chart

1 Month Animalcare Chart

1 Month Animalcare Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20211128 08:58:36